Founded in 2013, it is a state-level high-tech enterprise integrating drug research and development, production and sales. Covering an area of 100 mu, it has built a production and quality management system that meets the requirements of GMP and European and American drug quality management guidelines. It is a well-known domestic manufacturer of anti-influenza drugs, eye drops, weight loss drugs and apis, and has the R&D and production capacity of apis. There are 4 multi-functional API production workshops and independent drying kits, thousands of reaction equipment, complete storage facilities, with special chemical storage qualifications, with GMP requirements of oral solid preparation, eye drops, injections, film, ointment, liniment production workshop, oral solid preparation capacity of 500 million doses/year, eye drops of 100 million doses/year. Ability to undertake CMO/CDMO business with relevant dosage forms.